NCT05451212 2025-11-10
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Cabaletta Bio
Phase 1 Completed
Clinical Trials
5 trialsNCT06381284 2025-03-25
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
ZS Associates
Completed
NCT04695379 2023-10-06
CO-MY-COVID
University Hospital, Bordeaux
Completed
NCT03394859 2020-05-28
eMERGE
Vanderbilt University Medical Center
Completed
NCT03884777 2019-03-21
Incidence and Risk of Influenza in Myasthenic Patients
Centre d'Investigation Clinique et Technologique 805
Completed